News/ News/ R&D Merck & Co’s Keytruda shows potential in head and neck cancer use Piotr Wnuk Erbitux, Keytruda, Merck&Co, Opdivo 0 Comment Merck & Co might be able to find another use for its immunotherapy Keytruda in first line head Share X Merck & Co’s Keytruda shows potential in head and neck cancer use https://pharmaphorum.com/news/keytruda-shows-promise-first-line-skin-cancer-treatment/
Market Access/ News/ News Novartis freezes drug prices in a nod to Trump Piotr Wnuk Donald Trump, market access, Merck&Co, Novartis, pricing 0 Comment Novartis has announced it would not raise drug prices in the US this year, while Merck & Co Share X Novartis freezes drug prices in a nod to Trump https://pharmaphorum.com/news/novartis-freezes-drug-prices-in-a-nod-to-trump/
